FDA Approves Nerandomilast for Severe Lung Disease

Tablets for idiopathic pulmonary fibrosis are the first new treatment approved in more than 10 years.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-gives-nod-nerandomilast-severe-lung-disease-2025a1000raw?src=rss

Author :

Publish date : 2025-10-09 19:23:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

FDA Approves Nerandomilast for Severe Lung Disease

NIH Leaders Fired, CDC Gets Acting Center Directors, and Prasad Shapes FDA Team

Palliative Endoscopic Procedure Bests Surgery for Malignant GI Obstruction

Related Posts

Four health benefits of the outdoors

Therapy may be the most effective way to ease irritable bowel syndrome

Short-Interval HPV Retesting Shows Triage Promise for Cervical Cancer Screening

A Breast Cancer That’s Harder to Detect Is on the Rise

GLP-1s May Throw Off Some Medical Scans

1726-nm Laser Reduces Acne Lesions Across Skin Types

Four health benefits of the outdoors

Therapy may be the most effective way to ease irritable bowel syndrome

Short-Interval HPV Retesting Shows Triage Promise for Cervical Cancer Screening

A Breast Cancer That’s Harder to Detect Is on the Rise

GLP-1s May Throw Off Some Medical Scans

1726-nm Laser Reduces Acne Lesions Across Skin Types

Key Republican Senator Probes Major Source of AMA’s Revenue

Abortion Providers Say Missouri’s Attorney General Is Trying to Get Patient Records

Categories

Archives